Safety and effectiveness of hormonal contraception for women who use opioids: A systematic review

Heil, 2011, Unintended pregnancy in opioid-abusing women, J Subst Abuse Treat, 40, 199, 10.1016/j.jsat.2010.08.011

Black, 2012, Unplanned pregnancy and contraceptive use in women attending drug treatment services, Austr N Z J Obstet Gynaecol, 10.1111/j.1479-828X.2012.01413.x

Finer, 2016, Declines in unintended pregnancy in the United States, 2008–2011, N Engl J Med, 374, 843, 10.1056/NEJMsa1506575

Committee on Obstetric Practice, 2017, Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy, Obstet Gynecol, 130, e81, 10.1097/AOG.0000000000002235

Substance Abuse and Mental Health Services Administration, 2018

Handy, 2018, A retrospective chart review of contraceptive use among adolescents with opioid use disorder, J Pediatr Adolesc Gynecol, 31, 122, 10.1016/j.jpag.2017.11.002

Robinowitz, 2016, Family planning in substance use disorder treatment centers: opportunities and challenges, Subst Use Misuse, 51, 1477, 10.1080/10826084.2016.1188944

Fischbein, 2018, Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences, Contracept Reprod Med, 3, 4, 10.1186/s40834-018-0056-y

Cornford, 2015, Contraceptive use and pregnancy outcomes among opioid drug-using women: a retrospective cohort study, PLoS ONE [Electronic Resource], 10, 10.1371/journal.pone.0116231

Terplan, 2015, Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review, Prev Med, 80, 23, 10.1016/j.ypmed.2015.04.008

Committee opinion no. 633: alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice Obstet Gynecol 2015;125:1529–1537.

American Society of Addiction Medicine, 2017

Black, 2016, Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders, Substance Abuse, 10, 27

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535

Berry-Bibee, 2016, Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review, Contraception, 94, 650, 10.1016/j.contraception.2016.07.011

Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, 10.1136/bmj.d5928

Matusiewicz, 2017, Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder, Contraception, 96, 365, 10.1016/j.contraception.2017.07.167

Terplan, 2016, Reproductive health needs among substance use disorder treatment clients, J Addict Med, 10, 20, 10.1097/ADM.0000000000000175

Curtis, 2016, U.S. medical eligibility criteria for contraceptive use, 2016, MMWR Recomm Rep, 65, 1, 10.15585/mmwr.rr6503a1

Tepper, 2017, Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2016: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection, MMWR Morb Mortal Wkly Rep, 66, 990, 10.15585/mmwr.mm6637a6

Gavin, 2014, Providing quality family planning services: recommendations of CDC and the U.S. Office of population affairs, MMWR Recomm Rep, 63, 1

Griffith, 2017, Prescription contraception use and adherence by women with substance use disorders, Addiction, 112, 1638, 10.1111/add.13840

Callegari, 2015, Contraceptive adherence among women Veterans with mental illness and substance use disorder, Contraception, 91, 386, 10.1016/j.contraception.2015.01.013

Trussell, 2011, Contraceptive failure in the United States, Contraception, 83, 397, 10.1016/j.contraception.2011.01.021

Society for Adolescent Health and Medicine, 2017, The use of medication by adolescents and young adults, J Adolesc Health, 61, 396, 10.1016/j.jadohealth.2017.06.003

Dehlendorf, 2016, Association of the quality of interpersonal care during family planning counseling with contraceptive use, Am J Obstet Gynecol, 215, e1

Halpern, 2013, Strategies to improve adherence and acceptability of hormonal methods of contraception, Cochrane Database Syst Rev, CD004317

Dehlendorf, 2014, Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use, Clin Obstet Gynecol, 57, 659, 10.1097/GRF.0000000000000059

Higgins, 2016, Provider bias in long-acting reversible contraception (LARC) promotion and removal: perceptions of young adult women, Am J Public Health, 106, 1932, 10.2105/AJPH.2016.303393

Smith, 2009, Opioid metabolism, Mayo Clin Proc, 84, 613, 10.1016/S0025-6196(11)60750-7

Mercadante, 2015, Opioid metabolism and clinical aspects, Eur J Pharmacol, 769, 71, 10.1016/j.ejphar.2015.10.049

Orme, 1983, Clinical pharmacokinetics of oral contraceptive steroids, Clin Pharmacokinet, 8, 95, 10.2165/00003088-198308020-00001

Zhang, 2007, Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug, Clin Pharmacokinet, 46, 133, 10.2165/00003088-200746020-00003

Wilkinson, 2005, Drug metabolism and variability among patients in drug response, N Engl J Med, 352, 2211, 10.1056/NEJMra032424

Smith, 2011, The metabolism of opioid agents and the clinical impact of their active metabolites, Clin J Pain, 27, 824, 10.1097/AJP.0b013e31821d8ac1

Williams, 2004, Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios, Drug Metab Dispos, 32, 1201, 10.1124/dmd.104.000794

Zhang, 2018, Role of CYP3A in oral contraceptives clearance, Clin Transl Sci, 11, 251, 10.1111/cts.12499

Burkman, 2007, Transdermal hormonal contraception: benefits and risks, Am J Obstet Gynecol, 197, 134, 10.1016/j.ajog.2007.04.027

Winkler, 2015, Pharmacokinetic drug-drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate, Eur J Drug Metab Pharmacokinet, 40, 389, 10.1007/s13318-014-0215-8

Ramirez, 2004, CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes, Drug Metab Dispos, 32, 930

Knodell, 1982, Effects of ethinyl estradiol on pharmacokinetics of meperidine and pentobarbital in the rat, J Pharmacol Exp Ther, 221, 1

Shenfield, 1993, Oral contraceptives. Are drug interactions of clinical significance?, Drug Saf, 9, 21, 10.2165/00002018-199309010-00003

Stoehr, 1984, Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics, Clin Pharmacol Ther, 36, 683, 10.1038/clpt.1984.240

Simmons, 2018, Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review, BJOG, 125, 804, 10.1111/1471-0528.15027

Nanda, 2017, Drug interactions between hormonal contraceptives and antiretrovirals, AIDS, 31, 917, 10.1097/QAD.0000000000001392

Haberlen, 2017, Integration of family planning services into HIV care and treatment services: a systematic review, Stud Fam Plann, 48, 153, 10.1111/sifp.12018

Curtis, 2016, U.S. selected practice recommendations for contraceptive Use, 2016, MMWR Recomm Rep, 65, 1, 10.15585/mmwr.rr6504a1

Trauma-Informed Approach and Trauma-Specific Interventions. Substance Abuse and Mental Health Services Administration; 2018.

Higgins, 2014, Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach, Contraception, 89, 237, 10.1016/j.contraception.2014.01.027